Tag: NYSE DSS

Business

Document Security Systems Inc (NYSE: DSS) Subsidiary Impact BioMedical Inc. Announces Second U.S. Copyright Delivered for its Branded Equivir Composite

Document Security Systems Inc (NYSE: DSS) subsidiary Impact BioMedical Inc. announced that it has been issued copyright on June 15, 2021, from the U.S. Patent and Trademark Office for its branded composite Equivir.  Second copyright issues to the company for Equivir It is a follow-up to the discharge on April […]

Technology Stocks

Document Security Systems Inc.’s (NYSEAMERICAN: DSS) Subsidiary Impact Biomedical Offers Updates In Its Research Projects

Document Security Systems Inc.’s (NYSEAMERICAN: DSS) wholly-owned subsidiary Impact Biomedical Inc. has released several updates of its main research projects, including breakthroughs in treatment protocols, significant collaborations, and global licensing prospects. The announcement of the updates is a start for the next phase of Impact Biomedical’s research agenda and positioning […]

Business

Document Security Systems, Inc. (NYSEAMERICAN: DSS) Announced The Expansion Of DSS Securities, Inc With The Launch Of Liquid Value Asset Management Limited (LVAM)

Document Security Systems, Inc. (NYSEAMERICAN: DSS) has made official its plans to expand DSS Securities, Inc. The business expansion will occur through the company’s wholly-owned subsidiary DSS Financial Management Inc.’s Liquid Value Asset Management Limited (LVAM) launch, a fund management company based in Hong Kong. The fund will focus on […]